TEST ACCURACY

Academic Papers

■Tokyo Medical and Dental University “Applied research for POCT examination by micro blood sampling”

■Kagawa Prefectural Central Hospital "Implementation study of hepatitis medical examination by micro blood sampling"

■Okayama University Hospital "Management study of abnormal values of hepatitis and lifestyle-related diseases by micro blood sampling"

■Academic Journal

・Correlation of the Blood Test Results Obtained between Assays Using Microliter-scale Fingertip Blood Samples Collected with a Novel Blood Collection Device and Conventional Venous Blood Assays
KEIO JOURNAL OF MDECINE,DOI: 10.2302/kjm.2017-0009-OA

“新規採血用具によって採取した指頭微量血と通常の静脈血を試料とする血液検査値の相関について”

Kagawa Prefectural Chuo Hospital and Okayama University Hospital, under the guidance of MD Takaguchi, a specialist of liver internal medicine from Japan, are conducting clinical research on type B and C hepatitis C testing using our blood collection device.

香川県立中央病院、岡山大学病院

Cooperation: Kagawa Prefectural Central Hospital, Okayama University Hospital

Local governments in Japan have initiated the ""Know Hepatitis Project"" to promote hepatitis countermeasures, but there are still many undiagnosed patients.

We aim to realize an accurate screening test by simple fingertip blood collection anywhere in the city without the need to go to public health centers or medical institutions.

At the World Health Organization's (WHO) annual meeting (May 28, 2016), 194 member countries unanimously adopted a strategy for eradicating viral hepatitis by 2030 and declared that measures will be taken on a global scale. With the goal of eradicating hepatitis B and C viruses (HBV, HCV) by 2030, they will try to reduce the number of deaths annually by 65%, raise the number of treatments by 80%, and save 7.1 million people through prevention and treatment. The number of deaths due to hepatitis is 1.5 million every year, exceeding the number of deaths due to HIV, tuberculosis or malaria. At the background of this eradication declaration are the recent appearance of HCV drugs with high cure rate and HBV vaccines and effective therapeutic agents.

Test item which accuracy verification has been confirmed

・Total Protein(TP)・Albumin(ALB)・AST・ALT・γ-GTP
・Total Cholesterol(TC)・Triglycerides(TG) ・HDL-High Density Lipoprotein(HDL-C) ・LDL-Low Density Lipoprotein(LDL-C)
・Blood Urea Nitrogen(BUN) ・Creatine(CRE) ・Urinalysis(UA) ・HbA1c(NGSP)
・CEA ・PSA ・AFP ・CA19-9 ・CA15-3 ・CA125

New Cancer screeing tests, more specialized test items, genetic tests, etc., that can be tested using a small amount of serum separated in the laboratory as a sample, can be outsourced the testing to an external specialized organization via the laboratory.

Combination of Test Items

13 items of Lifestyle Related Diseases Liver Function Total Protein (TP) To detect protein disorder
Albumin (ALB) To detect nutritional status of the body, etc.
Aspartate Aminotransferase (AST) To detect abnormality in liver function and heart function
Alanine Aminotransferase (ALT) To detect liver function, especially degeneration of hepatocytes
Gamma-Glutamyl Transferase (γ-GTP) To detect liver function, especially alcoholic liver damage
Lipid metabolism Total Cholesterol (TC) To detect risk of arteriosclerosis
Triglycerides (TG) To detect risk of fatty liver, arteriosclerosis, etc.
High Density Lipoprotein (HDL-C) To detect risk of arteriosclerosis to combine with LDL-Cholesterol
Low Density Lipoprotein (LDL-C) To detect risk of arteriosclerosis
Kidney Function Blood Urea Nitrogen (BUN) To detect abnormality in kidney function
Creatine (CRE) To detect abnormality in kidney function
Uric Acid Uric Acid (UA) To detect risk of gout Glycometabolism
Glycometabolism HbA1c (NGSP) Hemoglobin A1c To detect risk of diabetes in average blood sugar level for last 3 months
Tumor Marker For Men Carcinoembryonic Antigen (CEA) Screening for digestive system cancer
Prostate Specific Antigen (PSA) Screening for prostate cancer
Alpha Fetoprotein (AFP) Screening for liver cancer
Pancreatic Cancer (CA19-9) Screening for pancreatic cancer, biliary cancer, gallbladder cancer
Tumor Marker For Women Carcinoembryonic Antigen (CEA) Screening for digestive system cancer
Metastatic Breast Cancer (CA15-3) Screening for metastatic breast cancer and ovarian cancer
Ovarian Cancer (CA125) Screening for ovarian cancer and uterine cancer
CA19-9 Pancreatic Cancer (CA19-9) Screening for pancreatic cancer, biliary cancer, gallbladder cancer

Contact Us

Inquiries by email

Inquiry Form